US · Healthcare

Reviva Pharmaceuticals Holdings Inc. (RVPH)

Biotechnology

Reviva Pharmaceuticals Holdings Inc. (RVPH) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for RVPH

P/E ratio

25.00

Reviva Pharmaceuticals Holdings Inc. (RVPH) — FAQ

What is RVPH's P/E ratio?

The price-to-earnings (P/E) ratio for Reviva Pharmaceuticals Holdings Inc. (RVPH) is 25.00 (data as of 2026-05-24).

Does Reviva Pharmaceuticals Holdings Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Reviva Pharmaceuticals Holdings Inc. (RVPH). Check the MyAverix Finance app for the latest dividend data.

What sector is Reviva Pharmaceuticals Holdings Inc. in?

Reviva Pharmaceuticals Holdings Inc. (RVPH) is classified in the Healthcare sector (Biotechnology industry).

What exchange is RVPH listed on?

RVPH is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)